<DOC>
	<DOCNO>NCT01374139</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence clinical tablet formulation ( 100 mg x 5 ) clinical capsule formulation ( 100 mg x 5 ) healthy subject feed condition ( Cohort 1 ) investigate effect high-fat meal pharmacokinetics bosutinib administration propose commercial tablet formulation ( 100 mg x 4 ) healthy subject ( Cohort 2 ) .</brief_summary>
	<brief_title>Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Philadelphia Chromosome</mesh_term>
	<criteria>Healthy male and/or female non childbearing potential subject age 21 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 Lead ECG clinical laboratory test . Pregnant nursing woman woman childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Bosutinib</keyword>
	<keyword>Bioequivalence Food Effect Studies</keyword>
</DOC>